Mavens Is Acquired by Komodo Health

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

January 11, 2021

Mavens, a leader in cloud-based technology solutions, has been acquired by Komodo Health.

Mavens brings together Komodo’s Healthcare Map™ and software suite with enterprise applications from Mavens, creating the most advanced data-driven, enterprise platform for healthcare and life sciences.

This deal will enable customers to more efficiently and seamlessly put life-saving therapies into the hands of patients who need them most. Deal terms were not disclosed.

“This acquisition disrupts the status quo, unlocking a fundamentally different opportunity for life sciences companies to gain access to differentiated insights through technology,” said Arif Nathoo, MD, CEO and co-founder of Komodo Health. “Purchasing fragmented and costly data assets, custom solutions and expensive consulting projects will be a thing of the past as Komodo Health delivers a seamless, data-driven platform across R&D, Commercial, Medical Affairs and Patient workflows.”

“Customers will benefit from our cloud-based enterprise platform that offers access to a suite of software solutions powered by our industry-leading Healthcare Map,” added Web Sun, President and co-founder of Komodo Health. “This will revolutionize the value that healthcare and life sciences companies can now realize.”

“We are excited to join forces with Komodo Health to create a next-generation solution for the industry,” said Prasad Kanumury (PK), founder and CEO of Mavens. “Together, we will transform the way life sciences companies support patients and providers, ultimately reducing the burden of disease across the globe. This raises the bar and changes the expectations of the entire healthcare ecosystem.”

Together, Komodo and Mavens will expand their software capabilities, powered by insights from Komodo’s Healthcare Map™ — which tracks more than 320 million de-identified patient journeys. As the industry shifts toward a patient-centered data model, enterprise healthcare companies can end their reliance on legacy data aggregators. The acquisition will also accelerate Komodo’s global expansion, as Mavens currently operates in the U.S., U.K. and India.

The acquisition of Mavens also comes on the heels of continued financial investment in Komodo Health, which raised $44 million in Series D funding led by ICONIQ Growth. Previous investors Andreessen Horowitz, Oak HC/FT, IA Ventures, Felicis Ventures, and McKesson Ventures all participated in the round. This funding will accelerate Komodo Health’s ability to expand its Healthcare Map, platform, and solutions and further accelerate its mission to reduce the global burden of disease.

“We have long admired Komodo’s achievements and we believe the company’s unique approach has finally linked robust patient journey data with crucial workflows to achieve greater efficiency and better outcomes in healthcare,” said Caroline Xie, General Partner, ICONIQ Growth. “With the acquisition of Mavens, Komodo extends its strategy deeper into the life sciences enterprise and remains well capitalized to accelerate its impact across the entire healthcare ecosystem.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.